European Archives - Page 305 of 1657 - European Medical Journal

EMJ Oncology 14 [Supplement 1] 2026

The European Society for Medical Oncology (ESMO) Congress 2025 featured important discussions on optimising treatment strategies for…

New Non-Invasive Biomarker for Heart Failure - EMJ

New Non-Invasive Biomarker for Heart Failure

Overexpression of hsa-miR-339-5p suppressed NLRC5, activated the PI3K/Akt signalling pathway, and significantly increased type 1 collagen and α-smooth muscle actin expression, indicating enhanced fibrotic remodelling.

Bimelkizumab Shows Long-term Effectiveness for Psoriasis - EMJ

Evidence Supports Effectiveness of Bimekizumab in Plaque Psoriasis

Real-world data from Italy show high two-year drug survival and sustained disease control with bimekizumab in moderate-to-severe plaque psoriasis.

Mental Disorders And Diabetes Care Disparities - EMJ

Unequal Diabetes Care for People with Mental Disorders

A global meta-analysis shows people with mental disorders receive poorer diabetes monitoring and less access to newer therapies.

AI Pathology Transforms NSCLC Molecular Triage - EMJ

AI Pathology Transforms NSCLC Molecular Triage

New data show that deep-learning classifiers can accurately identify key driver alterations in non-small cell lung cancer…

Universal Nirsevimab Cuts Infant RSV Hospitalisations - EMJ

Universal Nirsevimab Cuts Infant RSV Hospitalisations

Universal infant nirsevimab prophylaxis significantly reduced RSV-related hospitalisations and outpatient visits across two seasons in Spain.

Alcohol-related liver disease burden remains high - EMJ

Alcohol-Related Liver Disease Burden Remains High Despite Falling Consumption

New data show that alcohol-related liver disease continues to drive liver mortality, even where overall alcohol consumption has declined.

23 Jan 2026

Targeting Endothelin and Angiotensin in IgA Nephropathy

Endothelin-1 (ET-1) and angiotensin II (Ang II) overexpression is recognised as a mediator of disease progression in immunoglobulin…

$Stem Cell Eye Drops Show Early Promise in Refractory Dry Eye$

Stem Cell Eye Drops Improve Refractory Sjögren’s Dry Eye

A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and inflammation in refractory dry eye, including Sjögren’s syndrome.

Gestational Diabetes Tied to Widespread PFAS Chemicals

A major review links PFAS exposure to higher gestational diabetes risk, highlighting environmental chemicals as emerging pregnancy health concerns.